DBT organizes XII Indian MedTech Summit
- by Team ABLE - 10 Dec, 2018
The Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India held its XII Indian MedTech Summit on December 8, 2018. This annual event is organized by DBT under its flagship program-School of International Biodesign implemented at AIIMS and IITD in collaboration with International Partners with techno-legal management by BCIL.
The summit witnessed licensing of two medical device technologies coming out from SIB viz. CPR device technology transferred to M/S Rcupe LifesciencesPvt. Ltd., Bangalore and Haemorrhoid Treatment Device (ShortLiv) to M/s Slicic Innova, Bangalore by Biotech Consortium India Limited (BCIL) on behalf of DBT for further development and commercialization.
These novel patent protected technologies licensed during the summit aim to address a market size of more than $100 million in India and about $ 1 billion globally. Prof Paul congratulated DBT for licensing of technologies and taking technologies from R&D stage to translation and commercialization. The graduation ceremony of 2018 batch fellows was also held during the MedTech Summit.
The summit was highly successful and was attended by senior representatives from Government organizations, academia, medical device industry, start-ups, hospitals, and International organizations from Australia, Canada, Finland, Germany, India, Japan and Singapore. Dignitaries from Government of India included Dr Vinod Paul, Member Niti Ayog, Dr Renu Swarup, Secretary DBT, Dr, Balram Bhargava, DG-ICMR.
Dr. Renu Swarup during her key note address apprised the participants about the various initiatives of DBT for nurturing innovation ecosystem in the country including SIB as its flagship Program. She highlighted that one of the critical components of this ecosystem is funding for which a number of new schemes have been initiated by DBT-BIRAC to support and promote MedTech innovators. She informed that DBT has launched.
This annual event is organized by DBT under its flagship program-School of International Biodesign implemented at AIIMS and IITD in collaboration with International Partners with techno-legal management by BCIL.